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Purpose
The popular perception of herb-drug and drug-nutrient
interactions is that they are unintended and problematic.
Actually, purposeful coadministration of therapeutic
agents within a clinical strategy represents a valuable
approach to complex and evolving patient-centered care.
As individuals age, they are more likely to be prescribed
pharmaceutical medications: many also take herbs and
nutrients, which may interact. The occurrence of poly-
pharmacy may be orchestrated or unsupervised, benefi-
cial or risky, depending upon the individual patient’s
physiology, health status and medical condition(s) and
the communication and collaboration among the
involved healthcare providers.
Methods
A literature review was conducted using the following key-
words: polypharmacy, herb-drug interactions, nutrient-
drug interactions, safety, herbs, vitamins, minerals, amino
acids, essential fatty acids, physiologics, nutraceuticals,
nutritional supplements, adverse drug events, drug-
induced nutrient depletion, integrative healthcare delivery,
trans-disciplinary models, collaborative care, multidisci-
plinary care, therapeutic strategies, patient self-care,
patient-centered medicine, aging, middle-aged, elderly.
Results
The challenges of multidisciplinary care involving
diverse philosophical and clinical traditions bring forth
the opportunity and necessity of formulating new mod-
els of proactive polypharmacy focused on patient safety,
therapeutic efficacy and evidence-informed clinical-deci-
sion making. Patient demographics of medication, herb
and nutrient usage, adverse drug event occurrence, and
typical risk patterns are reviewed. Cardiovascular, degen-
erative bone and mind/mood conditions illustrate speci-
fic areas of concern.
Conclusion
Within the standard literature of pharmacy practice, sev-
eral clinical management tools have been developed for
eliciting, assessing, and managing multiple prescribed and
over the counter drugs. By extending the tools for coordi-
nating polypharmacy to encompass the full range of thera-
peutic agents, whether pharmaceutical, nutrient or
botanical, clinicians can formulate and implement a
patient-centered model of safe and effective polypharmacy.
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